{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-067555","form_type":"8-K","ticker":"RFL","cik":"0001713863","company_name":"Rafael Holdings, Inc.","filed_at":"2026-06-11T11:55:05+00:00","discovered_at":"2026-06-11T12:00:00.426721+00:00","generated_at":"2026-06-11T12:00:18.147878+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Rafael Holdings Q3 net loss $4.2M; Phase 3 NPC trial done, NDA submission H2 2026","bullets":["Net loss attributable to Rafael Holdings was $4.2M ($0.08/shr) vs $4.8M ($0.19/shr) a year ago.","Cash and equivalents stood at $30.5M as of April 30, 2026.","R&D expenses rose to $4.9M from $3.0M, driven by the March 2025 Cyclo acquisition.","Phase 3 TransportNPC trial completed last patient last visit; NDA submission expected in H2 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-067555","json":"https://secwatch.observer/filing/0001213900-26-067555.json","markdown":"https://secwatch.observer/filing/0001213900-26-067555.md","text":"https://secwatch.observer/filing/0001213900-26-067555.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713863/000121390026067555/0001213900-26-067555-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713863/000121390026067555/ea0294320-8k_rafael.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T12:00:18.147878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3ae3c5c325e815b6292232a73298c259a9752330","claim":"Rafael Holdings, Inc. reported the fiscal quarter ended April 30, 2026 results: net income net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share, EPS $0.08 per share.","evidence_excerpt":"For the three months ended April 30, 2026, we recorded a net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share, versus a net loss of $4.8 million, or $0.19 per share in the year ago period.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713863/000121390026067555/0001213900-26-067555-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal quarter ended April 30, 2026"},{"label":"Net income","value":"net loss attributable to Rafael Holdings of $4.2 million, or $0.08 per share"},{"label":"EPS","value":"$0.08 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"3cce1b2ed24a6f34ee29f26a6e47325a667f4c44","claim":"Rafael Holdings, Inc. reported the nine months ended April 30, 2026 results: net income net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share, EPS $0.40 per share.","evidence_excerpt":"For the nine months ended April 30, 2026, we recorded a net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share, versus a net loss of $18.4 million, or $0.73 per share in the year ago period.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713863/000121390026067555/0001213900-26-067555-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the nine months ended April 30, 2026"},{"label":"Net income","value":"net loss attributable to Rafael Holdings of $20.5 million, or $0.40 per share"},{"label":"EPS","value":"$0.40 per share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}